The event organizers selected Raleigh for their inaugural event given the Triangle region’s reputation for being an important ...

Because of Accelerate NC, Tina, Damon, and many others enjoy higher-than-average wages in a career with upward mobility, and ...

Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and ...

The new STTR grant will support the next phase of research, which will transition the radioisotope to copper-67 for potential therapeutic applications. Working with Lapi, Oncurie plans to optimize and ...

This free event will showcase North Carolina’s biologics and pharmaceutical (biopharma) manufacturing educational and career opportunities statewide. Hear from a panel of recent grads who have ...

AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs.

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...

Five of the Piedmont Triad region’s most impactful individuals and organizations in the life sciences have been honored with Excellence Awards. The awards were given at Triad BioNight, a celebration ...

Veteran business development specialist Paul Ulanch, Ph.D., M.B.A., has joined the North Carolina Biotechnology Center’s AgBiotech Group as Biotechnology Crops Development Director. Ulanch, director ...